{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:15:50Z","timestamp":1793171750834,"version":"4.5.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T00:00:00Z","timestamp":1393804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090411","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T16:54:20Z","timestamp":1393865660000},"page":"e90411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Bacteriophage Mediated Killing of Staphylococcus aureus In Vitro on Orthopaedic K Wires in Presence of Linezolid Prevents Implant Colonization"],"prefix":"10.1371","volume":"9","author":[{"given":"Sandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Harjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Chhibber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/321863","article-title":"New developments in diagnosis and treatment of infection in orthopaedic implants","volume":"33","author":"AF Widmer","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.biomaterials.2013.01.074","article-title":"The future of biologic coatings for orthopaedic implants","volume":"34(13)","author":"SB Goodman","year":"2013","journal-title":"Biomaterials"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4236\/jbise.2011.48069","article-title":"Prevention of Staphylococcus aureus biofilm formation on metallic surgical implants via controlled release of gentamicin","volume":"4","author":"DJ McMillan","year":"2011","journal-title":"Journal of Biomedical Science and Engineering"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"PS Stewart","year":"2001","journal-title":"The Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid0809.020063","article-title":"Biofilms: microbial life on surfaces","volume":"8","author":"RM Donlan","year":"2002","journal-title":"Emerging Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.qco.0000235161.85925.e8","article-title":"Infections associated with orthopaedic implants","volume":"19","author":"A Trampuz","year":"2006","journal-title":"Current Opinion in Infectious Diseases"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/BLO.0b013e3181123d4e","article-title":"Higher risk of failure of methicillin-resistant <italic>Staphylococcus aureus<\/italic> prosthetic joint infections","volume":"461","author":"CD Salgado","year":"2007","journal-title":"Clinical Orthopaedic Related Research"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s11999-008-0209-4","article-title":"Periprosthetic joint infection: the incidence, timing, and predisposing factors","volume":"466","author":"L Pulido","year":"2008","journal-title":"Clinical Orthopaedic Related Research"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1302\/0301-620X.90B3.20155","article-title":"Surgical site infection with methicillin-resistant <italic>Staphylococcus aureus<\/italic> after primary total hip replacement","volume":"90","author":"RJ Walls","year":"2008","journal-title":"Journal of Bone and Joint Surgery British Volume"},{"key":"ref10","volume":"107","unstructured":"Raschke MJ, Schmidmaier G (2004) Biological coating of implants in trauma and orthopedic surgery. Unfallchirurg <volume>107<\/volume>: : 653\u2013663, 2004."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00003086-199708000-00030","article-title":"Treatment of osteomyelitis with a biodegradable antibiotic implant","volume":"341","author":"JH Calhoun","year":"1997","journal-title":"Clinical Orthopaedic and Related Research"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.blo.0000126303.41711.a2","article-title":"Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model","volume":"421","author":"CG Ambrose","year":"2004","journal-title":"Clinical Orthopaedic and Related Research"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/02652040500162790","article-title":"Vancomycin biodegradable poly(lactideco-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release","volume":"22","author":"A Billon","year":"2005","journal-title":"Journal of Microencapsulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/jor.20193","article-title":"Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an <italic>in vitro<\/italic> and <italic>in vivo<\/italic> study","volume":"24","author":"T Kalicke","year":"2006","journal-title":"Journal of Orthopaedic Research"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1086\/533592","article-title":"Increasing antibiotic resistance among methicillin-resistant <italic>Staphylococcus aureus<\/italic> strains","volume":"46","author":"G Sakoulas","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for <italic>Staphylococcus aureus<\/italic>","volume":"44","author":"FC Tenover","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3410\/M4-4","article-title":"Reduced vancomycin susceptibility among clinical <italic>Staphylococcus aureus<\/italic> isolates (\u2018the MIC Creep\u2019): implications for therapy","volume":"4","author":"A Dhand","year":"2012","journal-title":"F1000 Medicine Reports"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/039139880502801103","article-title":"Biofilm in implant infections: its production and regulation","volume":"28","author":"JW Costerton","year":"2005","journal-title":"International Journal of Artificial Organs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/47.6.885","article-title":"Biomaterial associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery","volume":"47","author":"D Neut","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.addr.2012.03.015","article-title":"Immobilized antibiotics to prevent orthopaedic implant infections","volume":"64(12)","author":"NJ Hickok","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/clinchem\/37.10.1683","article-title":"Determination of silver in blood, urine, and tissues of volunteers and burn patients","volume":"37","author":"AT Wan","year":"1991","journal-title":"Clinical Chemistry"},{"key":"ref22","first-page":"553","article-title":"Biocompatibility of silver-modified polyesters for antimicrobial protection of prosthetic valves","volume":"6","author":"K Tweden","year":"1997","journal-title":"Journal of Heart Valve Disease"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/07853890108995959","article-title":"Bacteriophages as therapeutic agents","volume":"33","author":"A Sulakvelidze","year":"2001","journal-title":"Annals of Medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"A Sulakvelidze","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref25","first-page":"57","article-title":"Bacteriophage: potential treatment for bacterial infections","volume":"16","author":"D Duckworth","year":"2002","journal-title":"Biodrugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/138920108785161604","article-title":"The use of phages for the removal of infectious biofilms","volume":"9","author":"J Azeredo","year":"2008","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tibtech.2010.08.001","article-title":"Bacteriophages as potential new therapeutics to replace or supplement antibiotics","volume":"28","author":"M Kutateladze","year":"2010","journal-title":"Trends Biotechnology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/138920110790725410","article-title":"Phage therapy pharmacology","volume":"11","author":"ST Abedon","year":"2010","journal-title":"Current Pharmaceutical Biotechnology 2010"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijmm.2005.09.002","article-title":"Phage therapy: facts and fiction","volume":"296","author":"M Skurnik","year":"2007","journal-title":"International Journal of Medical Microbiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"C Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkf207","article-title":"Linezolid penetration into osteo-articular tissues","volume":"50","author":"B Rana","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/dkf066","article-title":"Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement","volume":"50","author":"AM Lovering","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/AAC.47.12.3964-3966.2003","article-title":"Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci","volume":"47","author":"F Kutscha-Lissberg","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.47.1.418-420.2003","article-title":"<italic>In vitro<\/italic> bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against <italic>Staphylococcus aureus<\/italic>","volume":"47","author":"P Grohs","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.48.2.546-555.2004","article-title":"Sub-inhibitory concentrations of linezolid reduce <italic>Staphylococcus aureus<\/italic> virulence factor expression","volume":"48","author":"K Bernardo","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jac\/dkf192","article-title":"Virulence factor expression by Gram-positive cocci exposed to sub-inhibitory concentrations of linezolid","volume":"50","author":"CG Gemmell","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/510396","article-title":"Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant <italic>Staphylococcus aureus<\/italic>","volume":"195","author":"DL Stevens","year":"2007","journal-title":"Journal of Infectious Diseases"},{"key":"ref38","unstructured":"Wayne PA (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7. Clinical and Laboratory Standards Institute."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1128\/AEM.02371-12","article-title":"Methicillin-resistant <italic>Staphylococcus aureus<\/italic> phage plaque size enhancement using sub-lethal concentrations of antibiotics","volume":"78","author":"S Kaur","year":"2012","journal-title":"Applied and Environmental Microbiology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1099\/jmm.0.018580-0","article-title":"Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by <italic>Klebsiella pneumoniae<\/italic> B5055","volume":"60","author":"S Kumari","year":"2011","journal-title":"Journal of Medical Microbiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1099\/jmm.0.05099-0","article-title":"Lysogeny and bacteriophage host range within the <italic>Burkholderia cepacia<\/italic> complex","volume":"52","author":"R Langley","year":"2003","journal-title":"Journal of Medicine Microbiology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2011.07.006","article-title":"Lyophilized inserts for nasal administration harboring bacteriophage selective for <italic>Staphylococcus aureus<\/italic>: in vitro evaluation","volume":"416 (1)","author":"M Alfadhel","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/dkg105","article-title":"Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology","volume":"51","author":"H Gollwitzer","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/jac\/dki106","article-title":"Antibacterial activity of linezolid and vancomycin in an <italic>in vitro<\/italic> pharmacodynamic model of gram-positive catheter-related bacteraemia","volume":"55","author":"NP Wiederhold","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref45","unstructured":"Patel SA (2012) Visible spectrophotometric method for estimation of linezolid in tablet and injection dosage form. International Journal of Pharmaceutical Research. 4(3)."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/47.5.647","article-title":"Mutation frequencies for resistance to fusidic acid and rifampicin in <italic>Staphylococcus aureus<\/italic>","volume":"47","author":"AJ O'Neill","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4684-7239-4_1","article-title":"Introduction to controlled release","volume":"47","author":"DR Cowsar","year":"1974","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/45.6.797","article-title":"Activity of linezolid against gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors","volume":"45","author":"M Fines","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: the first oxazolidinone antimicrobial","volume":"138","author":"RC Moellering","year":"2003","journal-title":"Annals of International Medicine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1586\/14787210.6.6.825","article-title":"Linezolid for the treatment of drug-resistant infections","volume":"6","author":"DJ Herrmann","year":"2008","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"ref51","first-page":"267","article-title":"Phage therapy: past history and future prospects","volume":"5","author":"RM Carlton","year":"1999","journal-title":"Archivum Immunologiae et Therapia Experimentalis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/153567601001500106","article-title":"Contained use of bacteriophages: risk assessment and biosafety recommendations","volume":"15 (1)","author":"C Verheust","year":"2010","journal-title":"Applied Biosafety"},{"key":"ref53","first-page":"1","article-title":"A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage form","volume":"5","author":"DA Alderman","year":"1984","journal-title":"International Journal of Pharmaceutical Technology and Product Manufacture"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1023\/A:1018975318805","article-title":"Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices","volume":"11","author":"AT Pham","year":"1994","journal-title":"Pharmaceutical Research"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(99)00204-5","article-title":"Controlled release of dual drug-loaded hydroxypropyl methyl cellulose matrix tablet using drug-containing polymeric coatings","volume":"188","author":"BJ Lee","year":"1999","journal-title":"International Journal of Pharmaceutics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(87)90172-4","article-title":"Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropyl methylcellulose matrix tablet","volume":"40","author":"JL Ford","year":"1987","journal-title":"International Journal of Pharmacy"},{"key":"ref57","first-page":"55","article-title":"Formulation of once a day controlled release tablet of indomethacin based on HPMC-Mannitol","volume":"1(5)","author":"R Pradhan","year":"2008","journal-title":"Journal of Science and Engineering Technology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2010.01.034","article-title":"Stabilization of bacteriophage during freeze drying","volume":"389","author":"U Puapermpoonsiri","year":"2010","journal-title":"International Journal of Pharmacy"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","article-title":"Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of <italic>Klebsiella pneumoniae B5055.<\/italic>","volume":"25","author":"MS Bedi","year":"2009","journal-title":"World Journal of Microbiology Biotechnology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1574-6976.2011.00277.x","article-title":"Analysis of antibiotic resistance regions in Gram-negative bacteria","volume":"35","author":"SR Partridge","year":"2011","journal-title":"FEMS Microbiology Reviews"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.49.3.1225-1228.2005","article-title":"Synergistic killing of <italic>Streptococcus pneumoniae<\/italic> with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance","volume":"49","author":"S Djurkovic","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T03:19:41Z","timestamp":1648437581000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090411"}},"subtitle":[],"editor":[{"given":"Karsten","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,3]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090411","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,3]]}}}